Interestingly, while DNMT1 inhibitors can lift the repression of tumor suppressors by promoter demethylation, they can also repress oncogenes that have been activated by gene body methylation, thereby normalizing the expression of both tumor suppressors and oncogenes [28,29]. The gene discussed is DNMT1; the disease is neoplasm.